Chemical activators of PRAME like 17 engage in various biochemical pathways to modulate the activity of this protein. Bisindolylmaleimide I, for instance, inhibits protein kinase C (PKC), a kinase that negatively regulates PRAME like 17 activation. By inhibiting PKC, Bisindolylmaleimide I removes this negative regulation, leading to the activation of PRAME like 17. Similarly, Forskolin raises intracellular cAMP levels, which in turn activate protein kinase A (PKA). Activated PKA can phosphorylate target proteins, including PRAME like 17, resulting in its activation. Ionomycin increases intracellular calcium levels, which can activate calmodulin-dependent kinase (CaMK). The activation of CaMK can then lead to the phosphorylation of PRAME like 17. Another activator, Phorbol 12-myristate 13-acetate (PMA), mimics diacylglycerol (DAG) and activates PKC, which can then phosphorylate and activate PRAME like 17.
In addition to these kinase modulators, activators such as Retinoic acid engage with the retinoic acid receptor (RAR)-mediated signaling pathway to induce modifications of PRAME like 17 that result in its activation. Trichostatin A (TSA) acts as a histone deacetylase (HDAC) inhibitor, modifying chromatin structure around PRAME like 17 to facilitate its activation. Epigallocatechin gallate (EGCG) inhibits DNA methyltransferases, potentially leading to the demethylation of the PRAME like 17 promoter region and its activation. Curcumin downregulates NF-κB, which is a negative regulator of PRAME like 17, thereby promoting its activation. Resveratrol activates sirtuins that may deacetylate proteins within the PRAME like 17 activation pathway. Sodium butyrate also acts as an HDAC inhibitor, leading to hyperacetylation of histones and potentially enhancing the expression of PRAME like 17. Piperlongumine raises levels of reactive oxygen species (ROS), which can activate redox-sensitive pathways to activate PRAME like 17. Lastly, Oltipraz modulates the Keap1-Nrf2 pathway, which can activate genes including PRAME like 17 by inducing the antioxidant response elements (AREs). All these chemicals, through their distinct molecular mechanisms, contribute to the regulation and activation of PRAME like 17.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
Bisindolylmaleimide I directly activates PRAME like 17 by inhibiting protein kinase C (PKC), which is negatively involved in the regulation of PRAME like 17 activation. Inhibition of PKC results in the activation of PRAME like 17 function. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin functions as a calcium ionophore, raising intracellular calcium levels which can activate calmodulin-dependent kinase (CaMK), leading to the phosphorylation and activation of downstream proteins including PRAME like 17. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates PRAME like 17 through the diacylglycerol (DAG) pathway, which activates PKC that could phosphorylate and thereby activate PRAME like 17. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid activates PRAME like 17 through the retinoic acid receptor (RAR)-mediated signaling pathway, which can lead to post-translational modifications of PRAME like 17 resulting in its activation. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A activates PRAME like 17 by inhibiting histone deacetylase (HDAC), which can lead to a more relaxed chromatin structure around PRAME like 17, facilitating its activation through increased accessibility to activating molecules. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG activates PRAME like 17 by inhibiting the activity of DNA methyltransferases, which could lead to demethylation of the PRAME like 17 promoter region, resulting in its activation. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin activates PRAME like 17 by downregulating the expression of NF-κB, a negative regulator of PRAME like 17, thereby leading to the activation of PRAME like 17. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates PRAME like 17 through sirtuin activation, which can deacetylate and activate proteins that are part of the PRAME like 17 pathway, leading to its functional activation. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate activates PRAME like 17 by acting as an HDAC inhibitor, which can lead to hyperacetylation of histones and a more open chromatin structure, potentially activating PRAME like 17 through increased gene expression. | ||||||
Piperlongumine | 20069-09-4 | sc-364128 | 10 mg | $107.00 | ||
Piperlongumine activates PRAME like 17 by increasing reactive oxygen species (ROS) levels, which can activate redox-sensitive signaling pathways that lead to the activation of PRAME like 17. | ||||||